A Phase 3 Trial of OPA-15406 Foam in Children and Infants With Atopic Dermatitis

Clinical trial NCT07184645 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07184645
Sponsor: Otsuka Pharmaceutical Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Atopic Dermatitis (AD)

Start date: 2025-09-01
Primary completion: 2027-02-01
Enrollment: 198

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.